Skip to main content
AmigoFish

Ashwagandha & Liver Injury: What Clinicians Need to Know with Dr Eric Viegas

From The Root Cause Medicine Podcast · · 12 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this Root Cause Medicine podcast episode, Dr. Kate Kresge is joined by Dr. Eric Viegas, quality and safety lead at Fullscript, to explore emerging concerns around ashwagandha-associated drug-induced liver injury (DILI). While ashwagandha remains one of the most widely used adaptogens in integrative medicine, recent international case reports have highlighted rare but clinically meaningful hepatic adverse events. This episode equips clinicians with a mechanistic understanding of potential risk factors, withanolide content that may increase vulnerability, and practical strategies for patient screening, education, and monitoring—without dismissing the therapeutic value of this foundational herb.

Clinical Takeaways from This Episode

- Ashwagandha-Associated Drug-Induced Liver Injury (DILI) Is Rare but Documented

- Case reports from Japan, Iceland, and the U.S. describe hepatocellular injury typically occurring within 2–12 weeks of initiation, often resolving after discontinuation (Björnsson, 2020).

- Withanone and Oxidative Stress as a Proposed Mechanism

- The withanolide withanone may contribute to genotoxic and oxidative stress, particularly in states of depleted glutathione, potentially impairing hepatic detoxification capacity (Siddiqui, 2021).

- Withanolide Concentration Matters

- Products standardized to high withanolide content may pose greater theoretical risk compared to traditional whole-root or aqueous preparations (Björnsson, 2020).

- Patient Vulnerability Influences Risk Profile

- Individuals with pre-existing liver concerns, polypharmacy, high oxidative stress burden, or impaired phase II detoxification may warrant closer consideration and monitoring (Siddiqui, 2021).

- Clinical-Grade Supply Chains Support Risk Mitigation

- Practitioner-dispensed platforms with transparent sourcing, certificates of analysis, and clear extract documentation may help reduce exposure to adulterated or mischaracterized products.

- Patient Education and Monitoring Remain Frontline Tools

- Counseling on symptom awareness and considering baseline and follow-up liver enzymes may support safer use when ashwagandha is clinically appropriate.

Guest Introduction

Dr. Eric Viegas is a quality expert at Fullscript, where he oversees supplement quality programs, supply chain integrity, and clinical-grade standards. With expertise in pharmacology, toxicology, and nutraceutical regulation, Dr. Viegas supports practitioners in making evidence-informed decisions around supplement sourcing, formulation, and patient safety. Learn more:https://fullscript.com (https://fullscript.com/)

Labs, Nutrition, and Lifestyle Support

Liver Function and Safety Monitoring Labs

- Comprehensive Metabolic Panel (CMP)

- ALT

- AST

- Total and direct bilirubin

- Alkaline phosphatase, as clinically indicated (Björnsson, 2020)

Nutritional Considerations for Hepatic Resilience

- Adequate dietary protein to support glutathione synthesis (Siddiqui, 2021)

Lifestyle and Integrative Support Strategies

- Review of total supplement and medication load with attention to polypharmacy

- Patient education on early symptoms of liver stress such as fatigue, pruritus, dark urine, and jaundice (Björnsson, 2020)

All strategies are intended for educational support and clinical consideration and should be applied within the context of individualized care.

Sponsor

This episode is sponsored by Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates), a comprehensive care delivery platform designed to support whole-person, integrative healthcare. Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates)allows clinicians to streamline supplement dispensing, lab ordering, and patient education in one free, centralized system—helping reduce administrative burden while supporting clinical decision-making. For practitioners,…

Back to The Root Cause Medicine Podcast · Report a problem